Clinical Trial Update: Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating nivolumab with radiation therapy and bevacizumab for recurrent MGMT-methylated glioblastoma; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING